LivaNova PLC - Asset Resilience Ratio

Latest as of December 2024: 0.00%

LivaNova PLC (LIVN) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of LivaNova PLC for a breakdown of total debt and financial obligations.

Liquid Assets

$42.00K
Cash + Short-term Investments

Total Assets

$2.51 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1998–2022)

This chart shows how LivaNova PLC's Asset Resilience Ratio has changed over time. See LIVN book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down LivaNova PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is LivaNova PLC worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $42.00K 0.0%
Total Liquid Assets $42.00K 0.00%

Asset Resilience Insights

  • Limited Liquidity: LivaNova PLC maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

LivaNova PLC Industry Peers by Asset Resilience Ratio

Compare LivaNova PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 3.37%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
Medical Devices 54.67%
Universus Photo Imagings Limited
NSE:UNIVPHOTO
Medical Devices 30.97%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%
Heramed Ltd
AU:HMD
Medical Devices 0.83%
Acarix A/S
ST:ACARIX
Medical Devices 37.81%

Annual Asset Resilience Ratio for LivaNova PLC (1998–2022)

The table below shows the annual Asset Resilience Ratio data for LivaNova PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.00% $-34.00K $2.29 Billion 0.00pp
2021-12-31 0.00% $-2.00K $2.20 Billion -1.30pp
2020-12-31 1.30% $31.09 Million $2.40 Billion +1.19pp
2018-12-31 0.10% $2.65 Million $2.55 Billion -0.01pp
2017-12-31 0.12% $2.94 Million $2.50 Billion +0.12pp
2016-12-31 0.00% $-8.00K $2.34 Billion -0.27pp
2015-12-31 0.27% $7.00 Million $2.56 Billion -8.23pp
2014-12-31 8.51% $25.03 Million $294.19 Million 0.00pp
2013-12-31 8.51% $25.03 Million $294.19 Million +2.79pp
2012-12-31 5.72% $15.10 Million $264.04 Million -1.36pp
2011-12-31 7.08% $15.00 Million $211.91 Million +6.60pp
2009-12-31 0.48% $1.00 Million $207.47 Million -0.20pp
2008-12-31 0.68% $1.00 Million $146.21 Million -0.27pp
2007-12-31 0.95% $1.00 Million $105.19 Million +0.22pp
2006-12-31 0.73% $1.00 Million $136.23 Million +0.08pp
2005-12-31 0.66% $1.00 Million $152.30 Million -22.41pp
2004-12-31 23.06% $22.80 Million $98.86 Million +22.98pp
2000-12-31 0.08% $57.54K $67.99 Million -3.80pp
1999-12-31 3.89% $1.56 Million $40.00 Million -44.35pp
1998-12-31 48.24% $19.20 Million $39.80 Million --
pp = percentage points

About LivaNova PLC

NASDAQ:LIVN USA Medical Devices
Market Cap
$3.33 Billion
Market Cap Rank
#4629 Global
#1494 in USA
Share Price
$61.00
Change (1 day)
+1.50%
52-Week Range
$35.16 - $71.00
All Time High
$130.95
About

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing syste… Read more